Clinical Trials Directory

Trials / Completed

CompletedNCT01653184

Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration

The Effect of Oral Supplementation With Omega-3 Fatty Acids on Serum Omega-3 Levels in Patients With Age-related Macular Degeneration: A Randomized Controlled Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Wills Eye · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

The effect of omega-3-fatty acids on blood levels omega-3 fatty acids in patients with age-related macular degeneration.

Detailed description

There is observational data in the current literature suggesting that the intake of foods high in marine sources of omega-3 fatty acids, such as fish, may lower the risk of developing age-related macular degeneration (AMD). A large prospective study is underway to determine whether oral supplementation with 1 gram of omega-3 fatty acids is beneficial for subjects with dry AMD. The purpose of our study is to evaluate the change in serum omega-3 index (blood level of omega-3 fatty acids) after 1 gram of omega-3 fatty acid supplementation versus 2 grams.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-3 fatty acidThe purpose of our study is to evaluate the change in serum omega-3 index (blood level of omega-3 fatty acids) after 1 gram of omega-3 fatty acid supplementation versus 2 grams.

Timeline

Start date
2012-07-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2012-07-30
Last updated
2016-12-12

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01653184. Inclusion in this directory is not an endorsement.